Insider transactions

EDGAR

BAXTER INTERNATIONAL INC

Transactions reported by directors, officers and 10% owners on SEC Forms 3, 4 and 5, read from each filing’s XML. Codes and their wording are the SEC’s own.

A Form 4 is due within two business days of the transaction, so the most recent trades may not be filed yet.

Window: transactions dated on or after 2025-11-20.

Open-market purchases (code P)
0 transactions, — shares
Open-market sales (code S)
0 transactions, — shares

Totals add the filed transactions listed; they are counts of what was reported, not a measure of direction.

Showing 1–45 of 45

Insider transactions, newest first, as filed on SEC Forms 3, 4 and 5
DateReporting ownerCodeAcquired or disposedSharesPrice per share, as filedValue (derived)Shares owned afterDirect or indirectRule 10b5-1 boxNotesSource
2026-09-02 Filed 2026-09-03Hider Andrew P. Director · Officer: President and CEO
F

Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3

Common Stock, $1 par value
Disposed (D)54,27625.70
1,394,893.2

Derived: shares × price per share. Exact value 1394893.20.

518,447Direct (D) No
F1, F2
  • F1 Represents the number of shares forfeited by the reporting person to cover the withholding of taxes incurred as a result of the delivery of shares on September 2, 2026 from the settlement of vested restricted stock units granted on September 2, 2025.
  • F2 Total includes the automatic reinvestment of dividends.
Open filing 0001628280-26-060476 Read from the filing’s XML Dispute this row
2026-09-02 Filed 2026-09-03Foster Julie Officer: President, Front Line Care
F

Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3

Common Stock, $1 par value
Disposed (D)2,09825.70
53,918.6

Derived: shares × price per share. Exact value 53918.60.

29,164Direct (D) No
F1, F2
  • F1 Represents the number of shares forfeited by the reporting person to cover the withholding of taxes incurred as a result of the delivery of shares on September 2, 2026 from the settlement of vested restricted stock units granted on September 2, 2025.
  • F2 Total includes the automatic reinvestment of dividends.
Open filing 0001628280-26-060469 Read from the filing’s XML Dispute this row
2026-09-01 Filed 2026-09-03Teaff James Officer: President, CCS
F

Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3

Common Stock, $1 par value
Disposed (D)75025.48
19,110

Derived: shares × price per share. Exact value 19110.00.

30,370Direct (D) No
F1, F2
  • F1 Represents the number of shares forfeited by the reporting person to cover the withholding of taxes incurred as a result of the delivery of shares on September 1, 2026 from the settlement of vested restricted stock units granted on September 1, 2023.
  • F2 Total includes the automatic reinvestment of dividends and shares held in the Baxter's Employee Stock Plan.
Open filing 0001628280-26-060479 Read from the filing’s XML Dispute this row
2026-06-02 Filed 2026-06-03Teaff James Officer: President, CCS
F

Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3

Common Stock, $1 par value
Disposed (D)32118.68
5,996.28

Derived: shares × price per share. Exact value 5996.28.

31,063Direct (D) No
F1, F2
  • F1 Represents the number of shares forfeited by the reporting person to cover the withholding of taxes incurred as a result of the delivery of shares on June 2, 2026, from the settlement of vested restricted stock units granted on June 2, 2025.
  • F2 Total includes shares held in the Baxter's Employee Stock Plan.
Open filing 0001628280-26-040214 Read from the filing’s XML Dispute this row
2026-06-02 Filed 2026-06-03Wallace Steven P. Officer: President, Adv. Surgery
F

Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3

Common Stock, $1 par value
Disposed (D)15318.68
2,858.04

Derived: shares × price per share. Exact value 2858.04.

70,128Direct (D) No
F1
  • F1 Represents the number of shares forfeited by the reporting person to cover the withholding of taxes incurred as a result of the delivery of shares on June 2, 2026, from the settlement of vested restricted stock units granted on June 2, 2025.
Open filing 0001628280-26-040222 Read from the filing’s XML Dispute this row
2026-06-01 Filed 2026-06-03Zielinski Anita A Officer: SVP, Interim CFO, CAO Cntrlr
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock, $1 par value
Acquired (A)13,4260—59,714Direct (D) No
F1, F2
  • F1 In connection with Ms. Zielinski's appointment to Interim CFO and commensurate with related additional duties, she received a one-time special grant award of restricted stock units which are scheduled to vest on the third anniversary of the grant date, subject to satisfaction of the related vesting requirements set forth in the Baxter International Inc. Second Amended and Restated 2021 Incentive Plan.
  • F2 Total includes the automatic reinvestment of dividends.
Open filing 0001628280-26-040231 Read from the filing’s XML Dispute this row
2026-05-05 Filed 2026-05-07McDonnell Michael R. Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock, $1 par value
Acquired (A)12,8360—14,647Direct (D) No
F1
  • F1 The reporting person received a grant of fully vested shares of common stock of Baxter International Inc., subject to the terms and conditions of the applicable grant.
Open filing 0001628280-26-032141 Read from the filing’s XML Dispute this row
2026-05-05 Filed 2026-05-07Craig Jeffrey A Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock, $1 par value
Acquired (A)12,8360—23,662Direct (D) No
F1, F2
  • F1 The reporting person received a grant of fully vested shares of common stock of Baxter International Inc., subject to the terms and conditions of the applicable grant.
  • F2 Total includes the automatic reinvestment of dividends.
Open filing 0001628280-26-032135 Read from the filing’s XML Dispute this row
2026-05-05 Filed 2026-05-07Shafer David Brent Director · Other: Chair of the Board
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock, $1 par value
Acquired (A)12,8360—72,804Direct (D) No
F1, F2
  • F1 The reporting person received a grant of fully vested shares of common stock of Baxter International Inc., subject to the terms and conditions of the applicable grant.
  • F2 Total includes the automatic reinvestment of dividends.
Open filing 0001628280-26-032168 Read from the filing’s XML Dispute this row
2026-05-05 Filed 2026-05-07Wendell Amy McBride Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock, $1 par value
Acquired (A)12,8360—44,235Direct (D) No
F1, F2
  • F1 The reporting person received a grant of fully vested shares of common stock of Baxter International Inc., subject to the terms and conditions of the applicable grant.
  • F2 Total includes the automatic reinvestment of dividends.
Open filing 0001628280-26-032190 Read from the filing’s XML Dispute this row
2026-05-05 Filed 2026-05-07MORRISON PATRICIA Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock, $1 par value
Acquired (A)12,8360—42,386Direct (D) No
F1, F2
  • F1 The reporting person received a grant of fully vested shares of common stock of Baxter International Inc., subject to the terms and conditions of the applicable grant.
  • F2 Total includes the automatic reinvestment of dividends.
Open filing 0001628280-26-032176 Read from the filing’s XML Dispute this row
2026-05-05 Filed 2026-05-07Wilkes David S. Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock, $1 par value
Acquired (A)12,8360—37,076Direct (D) No
F1, F2
  • F1 The reporting person received a grant of fully vested shares of common stock of Baxter International Inc., subject to the terms and conditions of the applicable grant.
  • F2 Total includes the automatic reinvestment of dividends.
Open filing 0001628280-26-032196 Read from the filing’s XML Dispute this row
2026-05-05 Filed 2026-05-07Ampofo William A. II Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock, $1 par value
Acquired (A)12,8360—30,375Direct (D) No
F1, F2
  • F1 The reporting person received a grant of fully vested shares of common stock of Baxter International Inc., subject to the terms and conditions of the applicable grant.
  • F2 Total includes the automatic reinvestment of dividends.
Open filing 0001628280-26-032127 Read from the filing’s XML Dispute this row
2026-05-05 Filed 2026-05-07SCHLICHTING NANCY M Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock, $1 par value
Acquired (A)12,8360—34,994Direct (D) No
F1, F2
  • F1 The reporting person received a grant of fully vested shares of common stock of Baxter International Inc., subject to the terms and conditions of the applicable grant.
  • F2 Total includes the automatic reinvestment of dividends.
Open filing 0001628280-26-032184 Read from the filing’s XML Dispute this row
2026-03-06 Filed 2026-03-10Grade Joel T. Officer: EVP and CFO
F

Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3

Common Stock, $1 par value
Disposed (D)8,15317.69
144,226.57

Derived: shares × price per share. Exact value 144226.57.

271,674Direct (D) No
F1
  • F1 Represents the number of shares forfeited by the reporting person to cover the withholding of taxes incurred as a result of the delivery of shares on March 6, 2026 from the settlement of vested restricted stock units granted on March 6, 2024 and March 6, 2025.
Open filing 0001628280-26-016401 Read from the filing’s XML Dispute this row
2026-03-06 Filed 2026-03-10Rosenbloom David S. Officer: EVP and General Counsel
F

Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3

Common Stock, $1 par value
Disposed (D)6,62017.69
117,107.8

Derived: shares × price per share. Exact value 117107.80.

138,216Direct (D) No
F1
  • F1 Represents the number of shares forfeited by the reporting person to cover the withholding of taxes incurred as a result of the delivery of shares on March 6, 2026 from the settlement of vested restricted stock units granted on March 6, 2024 and March 6, 2025.
Open filing 0001628280-26-016408 Read from the filing’s XML Dispute this row
2026-03-06 Filed 2026-03-10Soriano Maria Cecilia Officer: Group Pres., ITT Pharma.
F

Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3

Common Stock, $1 par value
Disposed (D)2,84817.69
50,381.12

Derived: shares × price per share. Exact value 50381.12.

75,045Direct (D) No
F1
  • F1 Represents the number of shares forfeited by the reporting person to cover the withholding of taxes incurred as a result of the delivery of shares on March 6, 2026 from the settlement of vested restricted stock units granted on March 6, 2024 and March 6, 2025.
Open filing 0001628280-26-016412 Read from the filing’s XML Dispute this row
2026-03-06 Filed 2026-03-10Zielinski Anita A Officer: SVP, CAO and Controller
F

Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3

Common Stock, $1 par value
Disposed (D)1,93217.69
34,177.08

Derived: shares × price per share. Exact value 34177.08.

46,281Direct (D) No
F1
  • F1 Represents the number of shares forfeited by the reporting person to cover the withholding of taxes incurred as a result of the delivery of shares on March 6, 2026 from the settlement of vested restricted stock units granted on March 6, 2025.
Open filing 0001628280-26-016420 Read from the filing’s XML Dispute this row
2026-03-06 Filed 2026-03-10Rasul Reazur Officer: EVP,Group Pres,Healthcare
F

Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3

Common Stock, $1 par value
Disposed (D)12,67417.69
224,203.06

Derived: shares × price per share. Exact value 224203.06.

125,557Direct (D) No
F1
  • F1 Represents the number of shares forfeited by the reporting person to cover the withholding of taxes incurred as a result of the delivery of shares on March 6, 2026 from the settlement of vested restricted stock units granted on March 6, 2024 and March 6, 2025.
Open filing 0001628280-26-016405 Read from the filing’s XML Dispute this row
2026-03-02 Filed 2026-03-03Soriano Maria Cecilia Officer: Group Pres., ITT Pharma.
F

Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3

Common Stock, $1 par value
Disposed (D)1,85219.69
36,465.88

Derived: shares × price per share. Exact value 36465.88.

77,894Direct (D) No
F2
  • F2 Represents the number of shares forfeited by the reporting person to cover the withholding of taxes incurred as a result of the delivery of shares on March 2, 2026 from the settlement of vested restricted stock units granted on March 1, 2023.
Open filing 0001628280-26-014241 Read from the filing’s XML Dispute this row
2026-03-02 Filed 2026-03-03Rasul Reazur Officer: EVP,Group Pres,Healthcare
F

Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3

Common Stock, $1 par value
Disposed (D)1,61419.69
31,779.66

Derived: shares × price per share. Exact value 31779.66.

138,231Direct (D) No
F1
  • F1 Represents the number of shares forfeited by the reporting person to cover the withholding of taxes incurred as a result of the delivery of shares on March 2, 2026 from the settlement of vested restricted stock units granted on March 1, 2023.
Open filing 0001628280-26-014243 Read from the filing’s XML Dispute this row
2026-03-02 Filed 2026-03-03Rosenbloom David S. Officer: EVP and General Counsel
F

Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3

Common Stock, $1 par value
Disposed (D)1,33619.69
26,305.84

Derived: shares × price per share. Exact value 26305.84.

144,837Direct (D) No
F2
  • F2 Represents the number of shares forfeited by the reporting person to cover the withholding of taxes incurred as a result of the delivery of shares on March 2, 2026 from the settlement of vested restricted stock units granted on March 1, 2023.
Open filing 0001628280-26-014239 Read from the filing’s XML Dispute this row
2026-02-27 Filed 2026-03-03Grade Joel T. Officer: EVP and CFO
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock, $1 par value
Acquired (A)42,7350—279,828Direct (D) No
F1, F2
  • F1 The reporting person received a grant of restricted stock units which are scheduled to vest in three equal annual installments beginning on March 1, 2027, the first anniversary of the grant date, subject to satisfaction of the related vesting requirements set forth in the Amended and Restated Baxter International Inc. 2021 Incentive Plan.
  • F2 Total includes shares held in the Baxter's Employee Stock Plan.
Open filing 0001628280-26-014236 Read from the filing’s XML Dispute this row
2026-02-27 Filed 2026-03-03Grade Joel T. Officer: EVP and CFO
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Stock Option (Right to Buy) — underlying Common Stock, $1 par value (103,448) — exercise price 20.37
Acquired (A)103,4480—103,448Direct (D) No
F3
  • F3 The options become exercisable in three equal annual installments beginning on March 1, 2027, the first anniversary of the grant date.
Open filing 0001628280-26-014236 Read from the filing’s XML Dispute this row
2026-02-27 Filed 2026-03-03Soriano Maria Cecilia Officer: Group Pres., ITT Pharma.
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock, $1 par value
Acquired (A)23,7420—79,748Direct (D) No
F1
  • F1 The reporting person received a grant of restricted stock units which are scheduled to vest in three equal annual installments beginning on March 1, 2027, the first anniversary of the grant date, subject to satisfaction of the related vesting requirements set forth in the Amended and Restated Baxter International Inc. 2021 Incentive Plan.
Open filing 0001628280-26-014241 Read from the filing’s XML Dispute this row
2026-02-27 Filed 2026-03-03Soriano Maria Cecilia Officer: Group Pres., ITT Pharma.
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Stock Option (Right to Buy) — underlying Common Stock, $1 par value (57,471) — exercise price 20.37
Acquired (A)57,4710—57,471Direct (D) No
F3
  • F3 The options become exercisable in three equal annual installments beginning on March 1, 2027, the first anniversary of the grant date.
Open filing 0001628280-26-014241 Read from the filing’s XML Dispute this row
2026-02-27 Filed 2026-03-03Carlisle Cynthia Officer: Executive Vice President, CHRO
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock, $1 par value
Acquired (A)17,8060—17,806Direct (D) No
F1
  • F1 The reporting person received a grant of restricted stock units which are scheduled to vest in three equal annual installments beginning on March 1, 2027, the first anniversary of the grant date, subject to satisfaction of the related vesting requirements set forth in the Amended and Restated Baxter International Inc. 2021 Incentive Plan (the Plan).
Open filing 0001628280-26-014245 Read from the filing’s XML Dispute this row
2026-02-27 Filed 2026-03-03Carlisle Cynthia Officer: Executive Vice President, CHRO
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock, $1 par value
Acquired (A)11,8710—29,677Direct (D) No
F2
  • F2 The reporting person received a grant of 11,871 restricted stock units all of which are scheduled to vest on February 27, 2029, subject to satisfaction of the related vesting requirements set forth in the Plan.
Open filing 0001628280-26-014245 Read from the filing’s XML Dispute this row
2026-02-27 Filed 2026-03-03Carlisle Cynthia Officer: Executive Vice President, CHRO
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Stock Option (Right to Buy) — underlying Common Stock, $1 par value (43,103) — exercise price 20.37
Acquired (A)43,1030—43,103Direct (D) No
F3
  • F3 The options become exercisable in three equal annual installments beginning on March 1, 2027, the first anniversary of the grant date.
Open filing 0001628280-26-014245 Read from the filing’s XML Dispute this row
2026-02-27 Filed 2026-03-03Zielinski Anita A Officer: SVP, CAO and Controller
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock, $1 par value
Acquired (A)30,8640—48,214Direct (D) No
F1, F2
  • F1 The reporting person received a grant of restricted stock units which are scheduled to vest in three equal annual installments beginning on March 1, 2027, the first anniversary of the grant date, subject to satisfaction of the related vesting requirements set forth in the Amended and Restated Baxter International Inc. 2021 Incentive Plan.
  • F2 Total includes the automatic reinvestment of dividends.
Open filing 0001628280-26-014234 Read from the filing’s XML Dispute this row
2026-02-27 Filed 2026-03-03Hider Andrew P. Director · Officer: President and CEO
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock, $1 par value
Acquired (A)201,8040—572,239Direct (D) No
F1, F2
  • F1 The reporting person received a grant of restricted stock units which are scheduled to vest in three equal annual installments beginning on March 1, 2027, the first anniversary of the grant date, subject to satisfaction of the related vesting requirements set forth in the Amended and Restated Baxter International Inc. 2021 Incentive Plan.
  • F2 Total includes the automatic reinvestment of dividends and shares held in the Baxter's Employee Stock Plan.
Open filing 0001628280-26-014248 Read from the filing’s XML Dispute this row
2026-02-27 Filed 2026-03-03Hider Andrew P. Director · Officer: President and CEO
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Stock Option (Right to Buy) — underlying Common Stock, $1 par value (488,506) — exercise price 20.37
Acquired (A)488,5060—488,506Direct (D) No
F3
  • F3 The options become exercisable in three equal annual installments beginning on March 1, 2027, the first anniversary of the grant date.
Open filing 0001628280-26-014248 Read from the filing’s XML Dispute this row
2026-02-27 Filed 2026-03-03Rosenbloom David S. Officer: EVP and General Counsel
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock, $1 par value
Acquired (A)26,7090—146,173Direct (D) No
F1
  • F1 The reporting person received a grant of restricted stock units which are scheduled to vest in three equal annual installments beginning on March 1, 2027, the first anniversary of the grant date, subject to satisfaction of the related vesting requirements set forth in the Amended and Restated Baxter International Inc. 2021 Incentive Plan.
Open filing 0001628280-26-014239 Read from the filing’s XML Dispute this row
2026-02-27 Filed 2026-03-03Rosenbloom David S. Officer: EVP and General Counsel
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Stock Option (Right to Buy) — underlying Common Stock, $1 par value (64,655) — exercise price 20.37
Acquired (A)64,6550—64,655Direct (D) No
F3
  • F3 The options become exercisable in three equal annual installments beginning on March 1, 2027, the first anniversary of the grant date.
Open filing 0001628280-26-014239 Read from the filing’s XML Dispute this row
2026-02-13 Filed 2026-02-18McDonnell Michael R. Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock, $1 par value
Acquired (A)1,8110—1,811Direct (D) No
F1
  • F1 The reporting person received a grant of fully vested shares of common stock of Baxter International Inc., subject to the terms and conditions of the applicable grant.
Open filing 0001628280-26-009023 Read from the filing’s XML Dispute this row
2026-02-09 Filed 2026-02-11Rasul Reazur Officer: EVP,Group Pres,Healthcare
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock, $1 par value
Acquired (A)18,9510—145,616Direct (D) No
F1
  • F1 Represents shares awarded from the performance share unit award granted on March 1, 2023 pursuant to the Amended Restated Baxter International Inc. 2021 Incentive Plan and the Annual Equity Program adopted by Baxter International Inc. (Baxter) (the 2023 PSUs). The award provided that one-third of the performance share units are awarded based on Baxter's Sales Compound Annual Growth Rate (Sales CAGR) performance, Baxter's Total Shareholder Return (TSR) performance, and Baxter's Total Return on Invested Capital (ROIC) performance over the three-year performance period January 1, 2023 to December 31, 2025 (the Three-Year Performance Period). These shares have vested as the Three-Year Performance Period has ended.
Open filing 0001628280-26-007416 Read from the filing’s XML Dispute this row
2026-02-09 Filed 2026-02-11Rasul Reazur Officer: EVP,Group Pres,Healthcare
F

Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3

Common Stock, $1 par value
Disposed (D)5,77021.73
125,382.1

Derived: shares × price per share. Exact value 125382.10.

139,846Direct (D) No
F2, F3
  • F2 Represents the number of shares forfeited by the reporting person to cover the withholding of taxes incurred as a result of the vesting of the 2023 PSUs.
  • F3 Total includes the automatic reinvestment of dividends.
Open filing 0001628280-26-007416 Read from the filing’s XML Dispute this row
2026-02-09 Filed 2026-02-11Rosenbloom David S. Officer: EVP and General Counsel
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock, $1 par value
Acquired (A)17,0550—124,689Direct (D) No
F1
  • F1 Represents shares awarded from the performance share unit award granted on March 1, 2023 pursuant to the Amended Restated Baxter International Inc. 2021 Incentive Plan and the Annual Equity Program adopted by Baxter International Inc. (Baxter) (the 2023 PSUs). The award provided that one-third of the performance share units are awarded based on Baxter's Sales Compound Annual Growth Rate (Sales CAGR) performance, Baxter's Total Shareholder Return (TSR) performance, and Baxter's Total Return on Invested Capital (ROIC) performance over the three-year performance period January 1, 2023 to December 31, 2025 (the Three-Year Performance Period). These shares have vested as the Three-Year Performance Period has ended.
Open filing 0001628280-26-007418 Read from the filing’s XML Dispute this row
2026-02-09 Filed 2026-02-11Rosenbloom David S. Officer: EVP and General Counsel
F

Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3

Common Stock, $1 par value
Disposed (D)5,22521.73
113,539.25

Derived: shares × price per share. Exact value 113539.25.

119,464Direct (D) No
F2, F3
  • F2 Represents the number of shares forfeited by the reporting person to cover the withholding of taxes incurred as a result of the vesting of the 2023 PSUs.
  • F3 Total includes the automatic reinvestment of dividends.
Open filing 0001628280-26-007418 Read from the filing’s XML Dispute this row
2026-02-09 Filed 2026-02-11Soriano Maria Cecilia Officer: Group Pres., ITT Pharma.
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock, $1 par value
Acquired (A)2,2730—56,924Direct (D) No
F1
  • F1 Represents shares awarded from the performance share unit award granted on March 1, 2023 pursuant to the Amended Restated Baxter International Inc. 2021 Incentive Plan and the Annual Equity Program adopted by Baxter International Inc. (Baxter) (the 2023 PSUs). The award provided that one-third of the performance share units are awarded based on Baxter's Sales Compound Annual Growth Rate (Sales CAGR) performance, Baxter's Total Shareholder Return (TSR) performance, and Baxter's Total Return on Invested Capital (ROIC) performance over the three-year performance period January 1, 2023 to December 31, 2025 (the Three-Year Performance Period). These shares have vested as the Three-Year Performance Period has ended.
Open filing 0001628280-26-007420 Read from the filing’s XML Dispute this row
2026-02-09 Filed 2026-02-11Soriano Maria Cecilia Officer: Group Pres., ITT Pharma.
F

Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3

Common Stock, $1 par value
Disposed (D)91821.73
19,948.14

Derived: shares × price per share. Exact value 19948.14.

56,006Direct (D) No
F2, F3
  • F2 Represents the number of shares forfeited by the reporting person to cover the withholding of taxes incurred as a result of the vesting of the 2023 PSUs.
  • F3 Total includes the automatic reinvestment of dividends.
Open filing 0001628280-26-007420 Read from the filing’s XML Dispute this row
2026-02-09 Filed 2026-02-11Grade Joel T. Officer: EVP and CFO
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock, $1 par value
Acquired (A)30,5040—246,048Direct (D) No
F1
  • F1 Represents shares awarded from the performance share unit award granted on March 1, 2023 pursuant to the Amended Restated Baxter International Inc. 2021 Incentive Plan and the Annual Equity Program adopted by Baxter International Inc. (Baxter) (the 2023 PSUs). The award provided that one-third of the performance share units are awarded based on Baxter's Sales Compound Annual Growth Rate (Sales CAGR) performance, Baxter's Total Shareholder Return (TSR) performance, and Baxter's Total Return on Invested Capital (ROIC) performance over the three-year performance period January 1, 2023 to December 31, 2025 (the Three-Year Performance Period). These shares have vested as the Three-Year Performance Period has ended.
Open filing 0001628280-26-007413 Read from the filing’s XML Dispute this row
2026-02-09 Filed 2026-02-11Grade Joel T. Officer: EVP and CFO
F

Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3

Common Stock, $1 par value
Disposed (D)9,14421.73
198,699.12

Derived: shares × price per share. Exact value 198699.12.

236,904Direct (D) No
F2, F3
  • F2 Represents the number of shares forfeited by the reporting person to cover the withholding of taxes incurred as a result of the vesting of the 2023 PSUs.
  • F3 Total includes the automatic reinvestment of dividends and shares held in the Baxter's Employee Stock Plan.
Open filing 0001628280-26-007413 Read from the filing’s XML Dispute this row
2025-12-12 Filed 2025-12-16Mason Jeanne K Officer: EVP, Chief HR Officer
F

Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3

Common Stock, $1 par value
Disposed (D)65019.15
12,447.5

Derived: shares × price per share. Exact value 12447.50.

199,853Direct (D) No
F1, F2
  • F1 Represents the number of shares forfeited by the reporting person to cover the withholding of accelerated Federal Insurance Contributions Act (FICA) taxes for restricted stock unit awards previously granted under Baxter International Inc.'s Long-Term Incentive Plan.
  • F2 Total includes the automatic reinvestment of dividends.
Open filing 0001628280-25-057326 Read from the filing’s XML Dispute this row
2025-12-01 Filed 2025-12-03Grade Joel T. Officer: EVP and CFO
F

Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3

Common Stock, $1 par value
Disposed (D)8,28819.08
158,135.04

Derived: shares × price per share. Exact value 158135.04.

215,151Direct (D) No
F1, F2
  • F1 Represents the number of shares forfeited by the reporting person to cover the withholding of taxes incurred as a result of the delivery of shares on December 1, 2025 from the settlement of vested restricted stock units granted on December 1, 2023.
  • F2 Total includes the automatic reinvestment of dividends.
Open filing 0001628280-25-054990 Read from the filing’s XML Dispute this row

Institutional holders (Form 13F)

Quarter ending 2026-09-30: 8,905 filings read, the latest filed 2026-11-19. Prior quarter ending 2026-06-30: 9,170 filings read.

Showing 1–50 of 776

Institutional holders, largest position first, as filed
ManagerShares or principalValue as filedChange from the prior quarterSource
BlackRock, Inc. Partly reported under another manager65,540,634 SH1,572,975,209 dollarsLower by 16,301,471 Prior quarter: 81,842,105Open filing 0002012383-26-003985 Filed 2026-11-13 Dispute this row
PZENA INVESTMENT MANAGEMENT LLC Partly reported under another manager62,425,636 SH1,498,215,264 dollarsLower by 2,869,757 Prior quarter: 65,295,393Open filing 0001027796-26-000065 Filed 2026-10-30 Dispute this row
Dodge Cox 55,651,965 SH1,335,647,160 dollarsLower by 2,734,380 Prior quarter: 58,386,345Open filing 0001193125-26-460252 Filed 2026-11-13 Dispute this row
FMR LLC Partly reported under another manager51,461,280 SH1,235,070,725 dollarsLower by 2,452,551 Prior quarter: 53,913,831Open filing 0000315066-26-002964 Filed 2026-11-10 Dispute this row
VANGUARD CAPITAL MANAGEMENT LLC 33,905,984 SH813,743,616 dollarsHigher by 151,704 Prior quarter: 33,754,280Open filing 0002100119-26-001711 Filed 2026-11-13 Dispute this row
VANGUARD PORTFOLIO MANAGEMENT LLC 23,414,852 SH561,956,448 dollarsLower by 642,338 Prior quarter: 24,057,190Open filing 0002100121-26-001150 Filed 2026-11-13 Dispute this row
STATE STREET CORP Partly reported under another manager20,624,883 SH495,201,590 dollarsHigher by 24,415 Prior quarter: 20,600,468Open filing 0000093751-26-000747 Filed 2026-11-12 Dispute this row
GEODE CAPITAL MANAGEMENT, LLC Partly reported under another manager13,932,393 SH333,776,151 dollarsLower by 191,296 Prior quarter: 14,123,689Open filing 0001214717-26-000012 Filed 2026-11-06 Dispute this row
GREENHAVEN ASSOCIATES INC 12,396,504 SH297,516,096 dollarsLower by 1,888,724 Prior quarter: 14,285,228Open filing 0001213900-26-112422 Filed 2026-10-26 Dispute this row
Invesco Ltd. Partly reported under another manager11,301,109 SH271,226,604 dollarsLower by 1,060,772 Prior quarter: 12,361,881Open filing 0000914208-26-000462 Filed 2026-11-12 Dispute this row
MORGAN STANLEY Partly reported under another manager7,761,829 SH186,283,947 dollarsHigher by 1,402,039 Prior quarter: 6,359,790Open filing 0000895421-26-000309 Filed 2026-11-13 Dispute this row
First Pacific Advisors, LP 7,725,403 SH185,409,672 dollarsHigher by 107,258 Prior quarter: 7,618,145Open filing 0001377581-26-000010 Filed 2026-11-12 Dispute this row
EQUITY INVESTMENT CORP 6,595,384 SH158,289,216 dollarsLower by 290,881 Prior quarter: 6,886,265Open filing 0001685771-26-000009 Filed 2026-11-04 Dispute this row
AQR CAPITAL MANAGEMENT LLC Partly reported under another manager6,554,833 SH153,678,066 dollarsHigher by 4,618,820 Prior quarter: 1,936,013Open filing 0001167557-26-000324 Filed 2026-11-16 Dispute this row
STATE FARM MUTUAL AUTOMOBILE INSURANCE CO Partly reported under another manager6,225,060 SH149,401,440 dollarsUnchanged Prior quarter: 6,225,060Open filing 0000315032-26-000005 Filed 2026-11-12 Dispute this row
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 6,191,744 SH148,601,856 dollarsHigher by 195,033 Prior quarter: 5,996,711Open filing 0000884546-26-000417 Filed 2026-11-16 Dispute this row
GOLDMAN SACHS GROUP INC Partly reported under another manager5,758,116 SH138,194,790 dollarsLower by 1,392,346 Prior quarter: 7,150,462Open filing 0000886982-26-000647 Filed 2026-11-16 Dispute this row
CITADEL ADVISORS LLC Partly reported under another manager4,981,495 SH119,555,880 dollarsHigher by 4,758,748 Prior quarter: 222,747Open filing 0001104659-26-128228 Filed 2026-11-16 Dispute this row
DIMENSIONAL FUND ADVISORS LP Partly reported under another manager4,934,320 SH118,396,397 dollarsLower by 677,824 Prior quarter: 5,612,144Open filing 0000354204-26-001096 Filed 2026-11-04 Dispute this row
NORTHERN TRUST CORP Partly reported under another manager4,699,291 SH112,782,984 dollarsLower by 164,713 Prior quarter: 4,864,004Open filing 0000073124-26-000067 Filed 2026-11-16 Dispute this row
BANK OF AMERICA CORP /DE/ Partly reported under another manager4,641,433 SH111,394,394 dollarsLower by 1,596,517 Prior quarter: 6,237,950Open filing 0000070858-26-000589 Filed 2026-11-16 Dispute this row
Russell Investments Group, Ltd. Partly reported under another manager3,327,791 SH79,762,389 dollarsHigher by 28,881 Prior quarter: 3,298,910Open filing 0001193125-26-451241 Filed 2026-11-06 Dispute this row
UBS Group AG Partly reported under another manager3,318,106 SH79,634,544 dollarsLower by 6,211,203 Prior quarter: 9,529,309Open filing 0001610520-26-000121 Filed 2026-11-10 Dispute this row
Bank of New York Mellon Corp Partly reported under another manager3,173,714 SH76,169,142 dollarsLower by 17,484 Prior quarter: 3,191,198Open filing 0001390777-26-000121 Filed 2026-11-05 Dispute this row
RWC Asset Management LLP 3,122,618 SH74,942,832 dollarsLower by 206,550 Prior quarter: 3,329,168Open filing 0001398344-26-018594 Filed 2026-10-22 Dispute this row
VANGUARD FIDUCIARY TRUST CO 2,919,311 SH70,063,464 dollarsHigher by 19,409 Prior quarter: 2,899,902Open filing 0000933478-26-000017 Filed 2026-11-13 Dispute this row
LSV ASSET MANAGEMENT Partly reported under another manager2,866,400 SH68,794 dollarsLower by 1,048,400 Prior quarter: 3,914,800Open filing 0001050470-26-000015 Filed 2026-11-06 Dispute this row
Freestone Grove Partners LP 2,551,035 SH61,224,840 dollarsHigher by 2,110,084 Prior quarter: 440,951Open filing 0001172661-26-005424 Filed 2026-11-16 Dispute this row
JPMORGAN CHASE CO Partly reported under another manager2,506,275 SH59,524,309 dollarsHigher by 142,136 Prior quarter: 2,364,139Open filing 0000019617-26-000404 Filed 2026-11-12 Dispute this row
EDMOND DE ROTHSCHILD HOLDING S.A. Partly reported under another manager2,183,278 SH52,398,672 dollarsLower by 253,774 Prior quarter: 2,437,052Open filing 0000947871-26-001003 Filed 2026-11-10 Dispute this row
DEUTSCHE BANK AG\ Partly reported under another manager1,991,416 SH47,793,984 dollarsLower by 80,226 Prior quarter: 2,071,642Open filing 0000948046-26-000083 Filed 2026-11-06 Dispute this row
RAYMOND JAMES FINANCIAL INC Partly reported under another manager1,861,258 SH44,670,200 dollarsLower by 254,644 Prior quarter: 2,115,902Open filing 0000720005-26-000081 Filed 2026-11-12 Dispute this row
FIL Ltd Partly reported under another manager1,784,245 SH42,821,880 dollarsLower by 1,156,306 Prior quarter: 2,940,551Open filing 0000318989-26-000202 Filed 2026-11-10 Dispute this row
THOMPSON SIEGEL WALMSLEY LLC Partly reported under another manager1,780,701 SH42,737 dollarsLower by 837,717 Prior quarter: 2,618,418Open filing 0001008322-26-000012 Filed 2026-11-05 Dispute this row
JONES FINANCIAL COMPANIES LLLP Partly reported under another manager1,720,457 SH40,208,100 dollarsLower by 685,750 Prior quarter: 2,406,207Open filing 0001193125-26-459442 Filed 2026-11-13 Dispute this row
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Partly reported under another manager1,703,691 SH40,888,584 dollarsHigher by 189,803 Prior quarter: 1,513,888Open filing 0000861177-26-000005 Filed 2026-11-16 Dispute this row
NATIXIS ADVISORS, LLC Partly reported under another manager1,587,947 SH38,111 dollarsLower by 728,016 Prior quarter: 2,315,963Open filing 0001018331-26-000013 Filed 2026-11-13 Dispute this row
AMERIPRISE FINANCIAL INC Partly reported under another manager1,571,575 SH37,718,443 dollarsHigher by 1,144,436 Prior quarter: 427,139Open filing 0001193125-26-463125 Filed 2026-11-16 Dispute this row
GENDELL JEFFREY L Partly reported under another manager1,561,899 SH37,485,576 dollarsLower by 193,999 Prior quarter: 1,755,898Open filing 0001214659-26-014144 Filed 2026-11-13 Dispute this row
MARSHALL WACE, LLP Partly reported under another manager1,505,045 SH36,121,080 dollarsLower by 3,352,222 Prior quarter: 4,857,267Open filing 0001318757-26-000012 Filed 2026-11-13 Dispute this row
TOCQUEVILLE ASSET MANAGEMENT L.P. 1,428,461 SH34,283,064 dollarsLower by 6,999 Prior quarter: 1,435,460Open filing 0000919574-26-007782 Filed 2026-11-13 Dispute this row
Front Street Capital Management, Inc. 1,283,209 SH30,797,016 dollarsLower by 36,783 Prior quarter: 1,319,992Open filing 0001683182-26-000005 Filed 2026-11-16 Dispute this row
CITIGROUP INC Partly reported under another manager1,263,552 SH30,325,242 dollarsHigher by 595,821 Prior quarter: 667,731Open filing 0000831001-26-000052 Filed 2026-11-04 Dispute this row
ENVESTNET ASSET MANAGEMENT INC 1,205,492 SH28,931,807 dollarsLower by 81,910 Prior quarter: 1,287,402Open filing 0001214659-26-014231 Filed 2026-11-16 Dispute this row
RHUMBLINE ADVISERS 1,173,631 SH28,167,144 dollarsHigher by 45,699 Prior quarter: 1,127,932Open filing 0001115418-26-000015 Filed 2026-11-10 Dispute this row
Vanguard Global Advisers, LLC 1,161,319 SH27,871,656 dollarsHigher by 81,396 Prior quarter: 1,079,923Open filing 0001811242-26-000017 Filed 2026-11-13 Dispute this row
NOMURA HOLDINGS INC Partly reported under another manager1,091,660 SH26,199,840 dollarsHigher by 1,066,596 Prior quarter: 25,064Open filing 0000905148-26-004867 Filed 2026-11-16 Dispute this row
WEDGE CAPITAL MANAGEMENT L L P/NC 1,065,501 SH25,572,024 dollarsNot in the prior quarter’s filings read Open filing 0001015308-26-000008 Filed 2026-10-13 Dispute this row
Auto-Owners Insurance Co 1,050,000 SH25,200,000 dollarsUnchanged Prior quarter: 1,050,000Open filing 0001964189-26-000005 Filed 2026-10-15 Dispute this row
Swiss National Bank 1,044,324 SH25,063,776 dollarsHigher by 8,500 Prior quarter: 1,035,824Open filing 0001582202-26-000008 Filed 2026-11-12 Dispute this row
Managers in the prior quarter with no filing read for the latest

They may simply not have filed yet: absent from the latest quarter’s filings read is not the same as a position sold.

  • Sixth Street Partners Management Company, L.P. 5,996,711 SH
  • NORGES BANK 4,144,905 SH
  • Holocene Advisors, LP 2,666,396 SH
  • Defilade Capital Management, L.P. 1,459,380 SH
  • Artisan Partners Limited Partnership 1,023,677 SH
  • Verition Fund Management LLC 464,280 SH
  • SG Americas Securities, LLC 339,656 SH
  • Jupiter Topco LLC 237,683 SH
  • MOORE CAPITAL MANAGEMENT, LP 192,227 SH
  • EASTERLY INVESTMENT PARTNERS LLC 179,600 SH
  • Walleye Trading LLC 168,400 SH
  • WELLINGTON MANAGEMENT GROUP LLP 137,400 SH
  • Callodine Capital Management, LP 107,922 SH
  • Arkadios Wealth Advisors 106,358 SH
  • Summit Trail Advisors, LLC 104,300 SH
  • 44 WEALTH MANAGEMENT LLC 98,330 SH
  • MANNING NAPIER ADVISORS LLC 96,959 SH
  • Pacer Advisors, Inc. 96,556 SH
  • Pinnacle Financial Partners, Inc. 72,888 SH
  • D. E. Shaw Co., Inc. 68,100 SH
  • D. E. Shaw Co., Inc. 56,200 SH
  • DARK FOREST CAPITAL MANAGEMENT LP 46,634 SH
  • NewEdge Wealth, LLC 43,244 SH
  • Kentucky Retirement Systems 32,338 SH
  • NOMURA ASSET MANAGEMENT INTERNATIONAL INC. 32,100 SH
  • Inscription Capital, LLC 20,841 SH
  • Premier Path Wealth Partners, LLC 19,188 SH
  • Addison Capital Co 17,961 SH
  • Jupiter Research Capital (Asia) Ltd 16,681 SH
  • TRANSCEND CAPITAL ADVISORS, LLC 16,472 SH
  • Arete Wealth Advisors, LLC 14,341 SH
  • TUDOR INVESTMENT CORP ET AL 13,900 SH
  • Kentucky Retirement Systems Insurance Trust Fund 13,420 SH
  • PFG Investments, LLC 11,249 SH
  • CHIRON CAPITAL MANAGEMENT, LLC 11,200 SH
  • Regatta Research Money Management 11,041 SH
  • SUMMIT SECURITIES GROUP LLC 10,238 SH
  • TWO SIGMA SECURITIES, LLC 9,960 SH
  • PCG Wealth Advisors, LLC 9,955 SH
  • Core Capital Management Research, inc. 9,461 SH
  • SevenBridge Financial Group, LLC 7,750 SH
  • Bayforest Capital Ltd 6,861 SH
  • MCF Advisors LLC 5,722 SH
  • Trust Asset Management LLC 5,677 SH
  • SALEM INVESTMENT COUNSELORS INC 5,300 SH
  • Steward Partners Investment Advisory, LLC 4,585 SH
  • Institute for Wealth Management, LLC. 4,356 SH
  • Compagnie Lombard Odier SCmA 3,700 SH
  • Arkadios Wealth Advisors 3,700 SH
  • NBT BANK, N.A. 2,417 SH
  • Form 13F covers long positions in Section 13(f) securities only: no short positions and no securities outside that list.
  • A manager that has not yet filed for the latest quarter is absent, not at zero; filings are due up to 45 days after quarter end.
  • A change is the difference between two quarter-end snapshots, not a trade.
  • A position reported under another manager may also appear in that manager’s filing; rows are not added together.
  • Holdings the securities list cannot place with this company, or places ambiguously, are not shown.

Trades by members of Congress

Periodic transaction reports filed by U.S. House members that name this company’s stock. Dates and amounts are as filed.

Showing 1–45 of 45

House members’ trades in this company, newest report first, as filed
MemberTransaction dateTypeAmountOwnerReport
Hon. Lisa McClain (MI09)2025-10-30Purchase$1,001 - $15,000SP2025-11-21
Hon. Lisa McClain (MI09)2025-10-30Sale$1,001 - $15,000SP2025-11-21
Hon. Lisa McClain (MI09)2025-10-31Sale$1,001 - $15,000SP2025-11-21
Hon. Lisa McClain (MI09)2025-09-25Purchase$1,001 - $15,000SP2025-10-22
Hon. Lisa McClain (MI09)2025-08-04Sale$1,001 - $15,000SP2025-09-12
Hon. Lisa McClain (MI09)2025-07-22Purchase$1,001 - $15,000SP2025-08-13
Hon. Rob Bresnahan (PA08)2025-05-15Purchase$1,001 - $15,0002025-06-09
Hon. Debbie Wasserman Schultz (FL25)2024-11-18Purchase$1,001 - $15,000DC2024-11-20
Hon. Earl Blumenauer (OR03)2024-07-09Purchase$15,001 - $50,000SP2024-08-06
Hon. Robert J. Wittman (VA01)2023-01-20Sale$1,001 - $15,0002023-02-15
Hon. William R. Keating (MA09)2022-12-05Sale$1,001 - $15,0002022-12-21
Hon. Robert J. Wittman (VA01)2022-07-15Purchase$1,001 - $15,0002022-08-10
Hon. Robert J. Wittman (VA01)2022-06-16Sale (partial)$1,001 - $15,0002022-07-08
Hon. William R. Keating (MA09)2021-03-17Purchase$1,001 - $15,0002021-04-27
Hon. William R. Keating (MA09)2021-04-14Purchase$1,001 - $15,0002021-04-27
Mr. Peter Meijer (MI03)2021-02-16Sale$1,001 - $15,0002021-03-16
Hon. Dean Phillips (MN03)2020-12-18Sale (partial)$1,001 - $15,0002021-01-09
Hon. Dean Phillips (MN03)2020-09-23Purchase$1,001 - $15,0002020-10-09
Hon. Lois Frankel (FL21)2020-05-27Sale$1,001 - $15,0002020-06-28
Hon. Dean Phillips (MN03)2020-04-02Purchase$1,001 - $15,0002020-05-07
Hon. Dean Phillips (MN03)2020-02-28Purchase$1,001 - $15,0002020-03-12
Hon. Lois Frankel (FL21)2020-01-29Sale (partial)$1,001 - $15,0002020-02-24
Hon. Dean Phillips (MN03)2019-11-22Sale$1,001 - $15,0002019-12-11
Hon. Dean Phillips (MN03)2019-09-11Sale (partial)$1,001 - $15,0002019-10-11
Hon. Dean Phillips (MN03)2019-08-13Purchase$1,001 - $15,0002019-09-16
Hon. Lois Frankel (FL21)2019-02-28Sale (partial)$1,001 - $15,0002019-03-27
Hon. Susie Lee (NV03)2019-02-27Sale$1,001 - $15,000JT2019-03-12
Hon. Gary Palmer (AL06)2017-11-27Sale$1,001 - $15,000SP2018-09-29
Hon. Lois Frankel (FL21)2018-07-18Sale (partial)$1,001 - $15,0002018-08-24
Hon. Richard L. Hanna (NY22)2016-12-28Sale$15,001 - $50,0002017-01-18
Hon. Mo Brooks (AL05)2016-08-31Sale$1,001 - $15,000JT2016-10-10
Hon. Frank A. LoBiondo (NJ02)2015-07-30Sale$1,001 - $15,0002016-07-20
Hon. Lois Frankel (FL22)2016-01-15Purchase$1,001 - $15,0002016-02-29
Hon. Lois Frankel (FL22)2016-01-15Purchase$1,001 - $15,0002016-01-28
Hon. Lois Frankel (FL22)2015-11-23Purchase$1,001 - $15,0002016-01-08
Hon. Raúl M. Grijalva (AZ03)2015-10-15Sale$1,001 - $15,0002015-11-02
Hon. Raúl M. Grijalva (AZ03)2015-07-29Purchase$1,001 - $15,0002015-08-13
Hon. K. Michael Conaway (TX11)2015-07-31Sale$1,001 - $15,0002015-08-03
Hon. K. Michael Conaway (TX11)2015-07-31Sale$1,001 - $15,000JT2015-08-03
Hon. K. Michael Conaway (TX11)2014-11-05Purchase$1,001 - $15,0002015-08-01
Hon. K. Michael Conaway (TX11)2015-06-09Sale$1,001 - $15,0002015-07-07
Hon. Richard L. Hanna (NY22)2015-05-19Purchase$1,001 - $15,0002015-06-15
Hon. Thomas MacArthur (NJ03)2015-05-27Sale$1,001 - $15,0002015-06-07
Hon. Thomas MacArthur (NJ03)2015-04-02Purchase$1,001 - $15,0002015-05-13
Hon. K. Michael Conaway (TX11)2014-11-18Purchase$1,001 - $15,0002014-12-02

5% holders (Schedule 13D and 13G)

Schedules filed in the SEC’s structured format (late 2024 onward) are read here. Earlier schedules are free text and are not read.

5% holders, newest event first, as filed
HolderPercent of classShares heldEvent dateFormSource
BlackRock Portfolio Management LLC Common Stock5.930,382,653.0009/30/2026 Filed 2026-10-27SCHEDULE 13G/AAmendment 3Open filing 0002052113-26-000976 Dispute this row
FMR LLC COMMON STOCK10.352,972,914.2705/29/2026 Filed 2026-06-05SCHEDULE 13G/AAmendment 2Open filing 0000315066-26-001410 Dispute this row
Abigail P. Johnson COMMON STOCK10.352,972,914.2705/29/2026 Filed 2026-06-05SCHEDULE 13G/AAmendment 2Open filing 0000315066-26-001410 Dispute this row
FMR LLC COMMON STOCK9.046,264,804.2803/31/2026 Filed 2026-05-06SCHEDULE 13G/AAmendment 1Open filing 0000315066-26-001099 Dispute this row
Abigail P. Johnson COMMON STOCK9.046,264,804.2803/31/2026 Filed 2026-05-06SCHEDULE 13G/AAmendment 1Open filing 0000315066-26-001099 Dispute this row
Vanguard Capital Management Common Stock7.3638,033,90703/31/2026 Filed 2026-04-29SCHEDULE 13GOpen filing 0002100119-26-000266 Dispute this row
BlackRock, Inc. Common Stock6.433,109,85203/31/2026 Filed 2026-04-27SCHEDULE 13G/AAmendment 12Open filing 0002012383-26-001734 Dispute this row
PZENA INVESTMENT MANAGEMENT LLC Common Stock12.765,347,621.0003/31/2026 Filed 2026-04-21SCHEDULE 13G/AAmendment 4Open filing 0001027796-26-000019 Dispute this row
The Vanguard Group Common Stock0003/13/2026 Filed 2026-03-26SCHEDULE 13G/AAmendment 11Open filing 0000102909-26-000758 Dispute this row
FMR LLC COMMON STOCK6.834,811,770.0412/31/2025 Filed 2026-02-05SCHEDULE 13GOpen filing 0000315066-26-000371 Dispute this row
Abigail P. Johnson COMMON STOCK6.834,811,770.0412/31/2025 Filed 2026-02-05SCHEDULE 13GOpen filing 0000315066-26-000371 Dispute this row
PZENA INVESTMENT MANAGEMENT LLC Common Stock13.870,866,049.0012/31/2025 Filed 2026-01-21SCHEDULE 13G/AAmendment 3Open filing 0001027796-26-000005 Dispute this row
BlackRock Portfolio Management LLC Common Stock8.744,925,341.0012/31/2025 Filed 2026-01-21SCHEDULE 13G/AAmendment 2Open filing 0002052113-26-000216 Dispute this row
Dodge Cox Common Stock11.257,396,37009/30/2025 Filed 2025-11-13SCHEDULE 13G/AAmendment 4Open filing 0001193125-25-280418 Dispute this row
BlackRock Portfolio Management LLC Common Stock7.639,204,985.0009/30/2025 Filed 2025-10-17SCHEDULE 13G/AAmendment 1Open filing 0002052113-25-003620 Dispute this row
PZENA INVESTMENT MANAGEMENT LLC Common Stock10.855,458,217.0008/31/2025 Filed 2025-09-02SCHEDULE 13G/AAmendment 2Open filing 0001027796-25-000045 Dispute this row
PZENA INVESTMENT MANAGEMENT LLC Common Stock7.739,708,226.0006/30/2025 Filed 2025-07-15SCHEDULE 13G/AAmendment 1Open filing 0001027796-25-000040 Dispute this row

Percent is of the class the filing names, as the holder stated it. Members of a group each report the group’s shares, so rows are not added together.

What was read

2,573,515 filings read, dated 2004-06-14 to 2026-11-19: Forms 3, 3/A, 4, 4/A, 5, 5/A.

Years can be incomplete while the archive is still being read. A year with few filings here is not a statement that few were made.

Filings read, by filing year
Filing yearFilings read
201517,857
2016222,642
2017222,009
2018223,345
2019216,482
2020199,806
2021249,835
2022231,682
2023229,674
2024234,045
2025235,520
2026262,405

Filings made before the SEC required XML are listed, not extracted.

Back to BAXTER INTERNATIONAL INC